Re-treating bleeding hereditary haemorrhagic telangiectasia with bevacizumab.
Oncology Department, Redcliffe Hospital, Brisbane, QLD, Australia. hogwoyaw@doctors.org.uk.
Gwo Yaw
GY
Ho
Edward
E
Zhong
Boris
B
Chern
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D006801:Humans; D008297:Male; D012008:Recurrence; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000175:diagnosis / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab